Celecoxib Combined with Thalidomide in the Treatment of Refractory Neoplastic Fever in Advanced Cholangiocarcinoma: A Case Report

Author Info

Qiu-yuan Liang Kaijian Lei Shan-Bing Wang Yue Ren Yan Xu

Corresponding Author

Kaijian Lei
Department of Oncology, The Second People’s Hospital of Yibin, Yibin, Sichuan, China

A B S T R A C T

Neoplastic fever, a common symptom of tumors, can be mainly controlled by nonsteroidal antiinflammatories (NSAIDs) and corticosteroids. However, there is no standard treatment guideline for refractory neoplastic fever, which cannot be controlled by the medicines mentioned above. This report presents a case of advanced cholangiocarcinoma with persistent fever lasting 3 weeks. After ineffective treatment with various antibiotics, ibuprofen, and corticosteroids, the body temperature returned to normal after a 48-hour treatment with celecoxib + thalidomide. Finally, the overall survival (OS) of the patient reached 8 months with radiotherapy and chemotherapy.

Article Info

Article Type

Case Report

Publication history

Received: Wed 02, Dec 2020
Accepted: Fri 18, Dec 2020
Published: Wed 23, Dec 2020

Copyright

© 2023 Kaijian Lei. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JSO.2020.06.06